Ibotenic acid lesions of the dorsal prefrontal cortex disrupt the expression of behavioral sensitization to cocaine

Neuroscience

Volumn 82, Issue 4, 1997, Pages 1103-1114

  Pierce, R C ^a   Reeder, D C ^a   Hicks, J ^a   Morgan, Z R ^a   Kalivas, P W ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Amygdala; Excitatory amino acid; Fimbria fornix; Glutamate; Nucleus accumbens; Thalamus

Indexed keywords

COCAINE; IBOTENIC ACID;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; DRUG ANTAGONISM; DRUG EFFECT; DRUG SENSITIZATION; MALE; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; THALAMUS;

EID: 0342617714     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00366-7     Document Type: Article

References (69)

1. Akimoto K., Hamamura T., Kazahaya Y., Akiyama K., Otsuki S. Enhanced extracellular dopamine level may be the fundamental neuropharmacological basis of cross-behavioral sensitization between methamphetamine and cocaine - an in vivo dialysis study in freely moving rats. Brain Res. 507:1990;344-346.
2. Banks K. E., Gratton A. Possible involvement of the prefrontal cortex in amphetamine-induced sensitization of mesolimbic dopamine function. Eur. J. Pharmac. 282:1995;157-167.
3. Bartlett E., Halldin A., Chapman B., Angrist B. Selective sensitization to psychosis-inducing effects of cocaine: a possible marker for addictive relapse vulnerability? Neuropsychopharmacology. 16:1997;77-82.
4. Bell K., Kalivas P. W. Context-specific cross sensitization between systemic cocaine and intra-accumbens AMPA infusion in rats. Psychopharmacology. 127:1996;377-383.
5. Berendse H. K., Galis D. E., Graaf Y., Groenewegen H. J. Topographical organization and relationship with ventral striatal compartments of prefrontal corticostriatal projections in the rat. J. comp. Neurol. 316:1992;314-367.
6. Berendse H. W., Groenewegen H. J. Organization of the thalamostriatal projections in the rat, with special emphasis on the ventral striatum. J. comp. Neurol. 299:1990;187-228.
7. Brog J. S., Salyapongse A., Deutch A. Y., Zahm D. S. The patterns of afferent innervation of the core and shell in the "accumbens" part of the ventral striatum: immunohistochemical detection of retrogradely transported Fluoro-Gold. J. comp. Neurol. 338:1993;255-278.
8. Browman K. E., Badiani A., Robinson T. E. Fimbria-fornix lesions do not block sensitization to the psychomotor activating effects of amphetamine. Pharmac. Biochem. Behav. 53:1996;899-902.
9. Brown E. E., Robertson G. S., Fibiger H. C. Evidence for conditional neuronal activation following exposure to a cocaine-paired environment: role of forebrain limbic structures. J. Neurosci. 12:1992;4112-4121.
10. Burns L. H., Robbins T. W., Everitt B. J. Differential effects of excitotoxic lesions of the basolateral amygdala, ventral subiculum and medial prefrontal cortex on responding with conditioned reinforcement and locomotor activity potentiated by intra-accumbens infusions of D-amphetamine. Behav. Brain Res. 55:1993;167-183.
11. Cador M., Bjijou Y., Stinus L. Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience. 65:1995;385-395.
12. Castaneda E., Becker J. B., Robinson T. E. The long-term effects of repeated amphetamine treatment in vivo on amphetamine, KCl and electrical stimulation evoked striatal dopamine release in vitro. Life Sci. 42:1988;2447-2456.
13. Childress A. R., Mozley D., Fitzgerald J., Reivich J., Jaggi J., O'Brien C. P. Limbic activation during cue-induced cocaine craving. Soc. Neurosci. Abstr. 25:1995;1956.
14. Dudai Y. (1989) The Neurobiology of Memory. Oxford University Press, Oxford.
15. Ellinwood E. H. Amphetamine psychosis. I. Description of the individuals and process. J. nerv. ment. Dis. 144:1967;273-283.
16. Fallon J. H., Moore R. Y. Catecholamine innervation of basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and striatum. J. comp. Neurol. 180:1978;545-580.
17. Goldman-Rakic P. S. Topography of cognition: parallel distributed networks in primate association cortex. A. Rev. Neurosci. 11:1988;137-156.
18. Groenewegen H. J., Vermeulen-Van der Zee A., Te Kortschot A., Witter M. P. Organization of the projections from the subiculum to the ventral striatum in the rat. A study using anterograde transport of Phaseolus vulgaris-leucoagglutinin. Neuroscience. 23:1987;103-112.
19. Heidbreder C. A., Thompson A. C., Shippenberg T. S. Role of extracellular dopamine in the initiation and long term expression of behavioral sensitization to cocaine. J. Pharmac. exp. Ther. 278:1996;490-502.
20. 1 dopamine receptor sensitivity within the rat nucleus accumbens. J. Pharmac. exp. Ther. 258:1991;882-890.
21. Higashi H., Inanaga K., Nishi S., Uchimura N. Enhancement of dopamine actions on rat nucleus accumbens neurones in vitro after methamphetamine pretreatment. J. Physiol. 408:1989;587-603.
22. Hooks M. S., Duffy P., Striplin C., Kalivas P. W. Behavioral and neurochemical sensitization following cocaine self-administration. Psychopharmacology. 115:1994;265-272.
23. Kalivas P. W. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res. Rev. 18:1993;75-113.
24. Kalivas P. W. (1995) Neural basis of behavioral sensitization to cocaine. In The Neurobiology of Cocaine (ed. Hammer R. P. Jr), pp. 81-98. CRC Press, Boca Raton, FL.
25. Kalivas P. W. and Barnes C. D. (1993) Limbic Motor Circuits in Neuropsychiatry. CRC Press, Boca Raton, FL.
26. Kalivas P. W., Duffy P. Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J. Neurosci. 13:1993;266-275.
27. Kalivas P. W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16:1991;223-244.
28. Kalivas P. W., Weber B. Amphetamine injection into the A10 dopamine region sensitizes rats to peripheral amphetamine, and cocaine. J. Pharmac. exp. Ther. 245:1988;1095-1102.
29. Karler R., Calder L. D., Bedingfield J. B. Cocaine behavioral sensitization and the excitatory amino acids. Psychopharmacology. 115:1994;305-310.
30. Karler R., Calder L. D., Turkanis S. A. DNQX blockade of amphetamine behavioral sensitization. Brain Res. 552:1991;295-300.
31. Kolta M. G., Shreve P., De Souza V., Uretsky N. J. Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine. Neuropharmacology. 24:1985;823-829.
32. Li Y., Wolf M. E. Ibotenic acid lesions of the prefrontal cortex do not prevent expression of behavioral sensitization to amphetamine. Behav. Brain Res. 84:1997;285-289.
33. Meredith G. E., Blank B., Groenewegen H. J. The distribution and compartmental organization of the cholinergic neurons in nucleus accumbens of the rat. Neuroscience. 31:1989;327-345.
34. oa in discrete regions of rat brain. J. Neurochem. 55:1990;1079-1082.
35. Nicholls D. G. The glutaminergic nerve terminal. Eur. J. Biochem. 212:1993;613-631.
36. Patrick S. L., Thompson T. L., Walker J. M., Patrick R. L. Concomitant sensitization of amphetamine-induced behavioral stimulation and in vivo dopamine release from rat caudate nucleus. Brain Res. 538:1991;343-346.
37. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edn. Academic, New York.
38. Peris J., Boyson S. J., Cass W. A., Curella P., Dwoskin L. P., Larson G., Lin L.-H., Yasuda R. P., Zahniser N. R. Persistence of neurochemical changes in dopamine systems after repeated cocaine administration. J. Pharmac. exp. Ther. 253:1990;38-44.
39. Pert A., Post R. and Weiss S. R. B. (1992) Conditioning as a critical determinant of sensitization induced by psychomotor stimulants. In Neurobiology of Drug Abuse: Learning and Memory (ed. Erinoff L.), pp. 208-241. NIDA, Washington, DC.
40. Pettit H. O., Pan H.-T., Parsons L. H., Justice J. B. Jr. Extracellular concentrations of cocaine and dopamine are enhanced during chronic cocaine administration. J. Neurochem. 55:1990;798-804.
41. Phillipson O. T., Griffiths A. C. The topographic order of inputs to the nucleus accumbens in the rat. Neuroscience. 16:1985;275-296.
42. Pierce R. C., Bell K., Duffy P., Kalivas P. W. Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J. Neurosci. 16:1996;1550-1560.
43. Pierce R. C., Duffy P., Kalivas P. W. Changes in excitatory amino acid transmission in the nucleus accumbens associated with behavioral sensitization to cocaine during early withdrawal. Neurosci. Net. 1008:1996;1-2.
44. Pierce R. C., Kalivas P. W. Amphetamine produces sensitized locomotion and dopamine release preferentially in the nucleus accumbens shell of rats administered repeated cocaine. J. Pharmac. exp. Ther. 275:1996;1019-1029.
45. Pierce R. C., Kalivas P. W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Rev. 00:1997;000-000.
46. Post R. M. and Weiss S. R. B. (1988) Sensitization and kindling: implications for the evolution of psychiatric symptomatology. In Sensitization in the Nervous System (eds Kalivas P. W. and Barnes C. D.), pp. 257-292. Telford, Caldwell, NJ.
47. Reid M. S., Berger S. P. Evidence for sensitization of cocaine-induced nucleus accumbens glutamate release. NeuroReport. 7:1996;1325-1329.
48. Robinson T. E., Becker J. B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11:1986;157-198.
49. Robinson T. E., Berridge K. C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18:1993;247-291.
50. Robinson T. E., Jurson P. A., Bennett J. A., Bentgen K. M. Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats. Brain Res. 462:1988;211-222.
51. Robinson T. E., Whishaw I. Q. Normalization of extracellular dopamine in the striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats. Brain Res. 450:1988;209-224.
52. Segal D. S., Geyer M. A. and Schuckit M. A. (1981) Stimulant-induced psychosis: an evaluation of animal models. In Essays in Neurochemistry and Neuropharmacology (eds Youdim M. B. H., Lovenberg W., Sharman D. F. and Lagnado J. R.), Vol. 5, pp. 95-129. John Wiley, London.
53. Sorg B. A., Davison D. L., Kalivas P. W., Prasad B. M. Repeated daily cocaine alters subsequent cocaine-induced increase of extracellular dopamine in the medial prefrontal cortex. J. Pharmac. exp. Ther. 281:1997;54-61.
54. Sorg B. A., Kalivas P. W. Effects of cocaine and footshock stress on extracellular dopamine levels in the medial prefrontal cortex. Neuroscience. 53:1993;695-703.
55. Stewart J. and Vezina P. (1988) Conditioning and behavioral sensitization. In Sensitization in the Nervous System (eds Kalivas P. W. and Barnes C. D.), pp. 207-224. Telford, Caldwell, NJ.
56. Striplin C., Kalivas P. W. Robustness of G protein changes in cocaine sensitization shown with immunoblotting. Synapse. 14:1993;10-15.
57. Terwilliger R., Beitner-Johnson D., Svarino K. A., Crain S. M., Nestler E. J. A general role for adaptations in G-proteins and cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res. 548:1991;100-110.
58. Vezina P., Stewart J. Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects. Brain Res. 516:1990;99-106.
59. Westerink B. H. C., Tuntler J., Damsma G., Rollema H., de Vries J. B. The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rat studies by brain dialysis. Naunyn-Schmiedeberg's Arch. Pharmac. 336:1987;502-507.
60. White F. J., Hu X.-T., Zhang X.-F., Wolf M. E. Repeated admnistration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system. J. Pharmac. exp. Ther. 273:1995;445-454.
61. Wolf M. E., Dahlin S. L., Hu X.-T., Xue C.-J., White K. Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine; comparison with N-methyl-D-aspartate antagonists. Neuroscience. 69:1995;417-439.
62. Wolf M. E., White F. J., Nassar R., Brooderson R. J., Khansa M. R. Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J. Pharmac. exp. Ther. 264:1993;249-255.
63. Wright C. I., Beijer V. J., Groenewegen H. J. Basal amygadaloid complex afferents to the rat nucleus accumbens are compartmentally organized. J. Neurosci. 16:1996;1877-1893.
64. Wright C. I., Groenewegen H. J. Patterns of convergence and segregation in the medial nucleus accumbens of the rat: relationships of prefrontal cortical, midline thalamic, and basal amygdaloid afferents. J. comp. Neurol. 361:1995;383-403.
65. Xue C.-J., Ng J. P., Li Y., Wolf M. E. Acute and repeated systemic amphetamine administration: effects on extracellular glutamate, aspartate, and serine levels in rat ventral tegmental area and nucleus accumbens. J. Neurochem. 67:1996;352-363.
66. Yoshikawa T., Shibuya H., Kaneno S., Toru M. Blockade of behavioral sensitization to methamphetamine by lesion of the hippocampo-accumbal pathway. Life Sci. 48:1991;1325-1332.
67. Yoshikawa T., Watanabe A., Shibuya H., Toru M. Involvement of the fimbria-fornix in the initiation but not the expression of methamphetamine-induced sensitization. Pharmac. Biochem. Behav. 45:1993;691-695.
68. Zaborszky L., Alheid G. F., Heimer L. Mapping of transmitter-specific connections: simultaneous demonstration of anterograde degeneration and changes in the immunostaining pattern induced by lesions. J. Neurosci. Meth. 14:1985;255-266.
69. Zahm D. S., Heimer L. Ventral striatopallidal parts of the basal ganglia in the rat: I. Neurochemical compartmentation as reflected by the distributions of neurotensin and substance P immunoreactivity. J. comp. Neurol. 272:1988;516-525.